Mark Hurtt is currently an advisor at Lassogen, but they have also been a medical director and drug development director at Pfizer, a chief medical officer at Alseres Phamaceuticals, and a private practice neurologist. Mark has also worked as an assistant professor of neurology and neuropathology at the University of Pittsburgh School of Medicine and as a medical officer for the United States Navy. Their internship was in internal medicine at Thomas Jefferson University Hospital.
Mark Hurtt attended Penn State University for their Bachelor of Science and then Thomas Jefferson University for their Doctor of Medicine. Mark is certified from The American Board of Pathology in Neuropathology and the American Board of Psychiatry and Neurology, Inc. in Neurology.
This person is not in the org chart